Nextech3D.AI is sponsoring and providing AI-powered technology for The Event Planner Expo 2026 in New York City from October 27 to 29. The company will deliver a keynote on agentic AI, highlighting a shift to AI-native event platforms that use natural language for workflow management. At the expo, Nextech3D.AI will showcase its Agentic AI Event Platform and KraftyLab team-building platform, along with new AI features for its Map D floor-plan management system. Their broader goal is to integrate these tools into a unified AI-native platform covering the entire event lifecycle, from planning to lead retrieval, aiming to capture a larger market opportunity beyond individual AI features.
Nextech3D.ai's sponsorship and AI technology for Event Planner Expo provide context for technology sector trends. For readers following the Technology sector, here is Pluang's market snapshot as of Oct 19, 2026 19:31 WIB: out of 150 priced US tech stocks, 93 rose and 46 fell. Notable movers include Applied Digital Corporation (APLD) at USD 19.59 with an 8.53% increase, Nebius Group NV (NBIS) at USD 177.57 up 7.31%, and Aehr Test Systems (AEHR) at USD 64.98 rising 7.23%.
Disc Medicine's stock surged 38% following positive Phase 3 trial results for its drug bitopertin, which showed efficacy and safety in treating erythropoietic protoporphyria. BMO Capital raised its price target from $100 to $120 and maintained an Out...
Qualcomm executive Ann C. Chaplin sold 1,827 shares of the company's stock for $319,268.25 under a Rule 10b5-1 trading plan, reducing her holdings by 6.62%. Qualcomm's stock price recently traded below its 50-day and 200-day moving averages, signalin...
BOK Financial is set to announce its Q3 2026 earnings after market close on October 19, with analysts forecasting earnings per share between $2.52 and $2.54 and revenue near $571 million. The company has a strong history of surpassing earnings estima...
AIBotics has completed the acquisition of NovaCore Labs' assets from PlayJamaica Limited, gaining technology, software, drones, mapping equipment, and customer contracts. This move expands AIBotics' platform in Jamaica and the Caribbean, enhancing AI...
EyePoint's stock dropped sharply after its DURAVYU treatment did not meet the primary endpoint in a Phase 3 trial for wet age-related macular degeneration (wet AMD). Although DURAVYU showed some vision improvement and reduced the need for additional ...
